This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Jaundice is a condition that results when there is an excess of a yellow pigment called bilirubin in the blood. This can be caused by a variety of medical conditions, including liver disease, gallstones, and a side effect of certain medications. Jaundice is usually visible as a yellow tint in the skin and the whites of the eyes, but can also manifest in other areas, such as the mucous membranes. The body produces bilirubin as a result of the breakdown of red blood cells. When the liver is functioning properly, it can quickly process and remove bilirubin from the blood. However, when the liver is damaged or not working properly, bilirubin can build up, causing jaundice. In some cases, jaundice can also be caused by an obstruction of the bile ducts, which prevents the bilirubin from being removed from the body properly. Jaundice can present with a variety of symptoms, including fatigue, itching, dark urine, pale stools, abdominal pain, and loss of appetite. In some cases, jaundice can also lead to complications such as anaemia, gallstones, and liver failure. If you suspect you have jaundice, it is important to seek medical attention as soon as possible. Your doctor will likely perform a physical examination and take blood tests to determine the cause of the jaundice and the best course of treatment. Treatment may include medications, surgery, or lifestyle changes, depending on the cause of the jaundice.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States